Blood Cell Technologies, LLC 

Blood Cell Technologies, LLC is an early-stage research and development biotechnology company with a focus on identifying, validating, and commercializing novel drug targets and compounds that may be used to diagnose or treat blood cell disorders. The initial focus of the company is development of a first-in-class redox-inhibiting compound to enhance platelet production in humans.

Contact Information:

Wadie F. Bahou, MD, Founder and CEO
Phone:  631-751-3467